Duration of antiretroviral regimens in treatment-experienced patients in clinical practice

被引：0
|
作者：
Vicente Escudero Vilaplana
Sergio Plata Paniagua
Nicolas Trovato Lopez
Isabel Castillo Romera
Arantza Ais Larisgoitia
Jose Maria Bellon Cano
Maria Sanjurjo Saez
机构：
[1] Hospital General Universitario Gregorio Marañon,
来源：
Retrovirology | / 7卷
关键词：
Control Variable; Viral Load; Primary Endpoint; Treatment Failure; Efavirenz;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] MIXED-TREATMENT COMPARISON OF THE EFFICACY AND SAFETY OF ANTIRETROVIRAL DRUGS INDICATED FOR TREATMENT-EXPERIENCED HIV PATIENTS
    Cure, S.
    Bianic, F.
    Shelbaya, A.
    Portsmouth, S.
    Jones, E. C.
    Martin, M.
    Despiegel, N.
    VALUE IN HEALTH, 2012, 15 (07) : A385 - A385
  • [32] The MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients
    van Lelyveld, Steven F. L.
    Wensing, Annemarie M. J.
    Hoepelman, Andy I. M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (11) : 1241 - 1247
  • [33] Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients
    Cordery, Damien V.
    Hesse, Karl
    Amin, Janaki
    Cooper, David A.
    ANTIVIRAL THERAPY, 2010, 15 (07) : 1035 - 1038
  • [34] Response to 'limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analvsis'
    Badri, SM
    Adeyemi, OM
    Max, BE
    Barker, DE
    AIDS, 2005, 19 (11) : 1241 - 1242
  • [35] Characteristics of heavily treatment-experienced (HTE) people with HIV (PWHIV) in US clinical practice
    Eron, J.
    Dunbar, M.
    Radtchenko, J.
    Gruber, J.
    Huhn, G.
    McComsey, G.
    Temme, L.
    Thompson, J.
    Elion, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 92 - 93
  • [36] Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: Predictors of virological response and drug resistance evolution in a multi-cohort study
    S. Di Giambenedetto
    C. Torti
    M. Prosperi
    N. Manca
    G. Lapadula
    G. Paraninfo
    N. Ladisa
    M. Zazzi
    M. Trezzi
    P. Cicconi
    P. Corsi
    P. Nasta
    R. Cauda
    A. De Luca
    Infection, 2009, 37 : 438 - 444
  • [37] Effectiveness of Antiretroviral Regimens Containing Abacavir with Tenofovir in Treatment-Experienced Patients: Predictors of Virological Response and Drug Resistance Evolution in a Multi-Cohort Study
    Di Giambenedetto, S.
    Torti, C.
    Prosperi, M.
    Manca, N.
    Lapadula, G.
    Paraninfo, G.
    Ladisa, N.
    Zazzi, M.
    Trezzi, M.
    Cicconi, P.
    Corsi, P.
    Nasta, P.
    Cauda, R.
    De Luca, A.
    INFECTION, 2009, 37 (05) : 438 - 444
  • [38] The use of integrase inhibitors in treatment-experienced patients
    Gatell J.M.
    European Journal of Medical Research, 14 (Suppl 3) : 30 - 35
  • [39] Genetic diversity of integrase (IN) sequences in antiretroviral treatment-naive and treatment-experienced HIV type 2 patients
    Xu, L.
    Anderson, J.
    Ferns, B.
    Cook, P.
    Wildfire, A.
    Workman, J.
    Graham, S.
    Smit, E.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (07) : 1003 - 1007
  • [40] Efficacy of raltegravir-containing regimens in antiretroviral-naive and -experienced individuals in routine clinical practice
    Jaeckle, M.
    Khaykin, P.
    Haberl, A.
    De Leuw, P.
    Schuettfort, G.
    Stephan, C.
    Wolf, T.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (13) : 1170 - 1179
12345